{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Measles%2C+Mumps%2C+Rubella+and+Varicella", "query": { "intervention": "Measles, Mumps, Rubella and Varicella" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 42, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Measles%2C+Mumps%2C+Rubella+and+Varicella&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-10T16:49:51.964Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01702428", "title": "Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rubella", "Measles", "Mumps" ], "interventions": [ { "name": "Priorix", "type": "BIOLOGICAL" }, { "name": "M-M-R II", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" }, { "name": "Havrix", "type": "BIOLOGICAL" }, { "name": "Prevnar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 5016, "start_date": "2012-11-09", "completion_date": "2015-04-16", "has_results": true, "last_update_posted_date": "2019-11-25", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 62, "location_summary": "Dothan, Alabama • Phoenix, Arizona • Fayetteville, Arkansas + 56 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Daly City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01702428" }, { "nct_id": "NCT00422292", "title": "Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, Rubella and Varicella", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "9 Months to 12 Months" }, "enrollment_count": 1664, "start_date": "2006-12", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 87, "location_summary": "Tuscaloosa, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 74 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Atascadero", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00422292" }, { "nct_id": "NCT05095844", "title": "National Vaccine Adverse Event Reporting Survey and Etiology", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID-19", "Vaccine Adverse Reaction", "Vaccine Reaction", "Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use", "Corona Virus Infection", "Blood Clot", "Thrombocytopenia", "Neuritis", "Vasculitis", "Influenza", "Guillain-Barré", "GWAS", "Genetic Sequencing" ], "interventions": [ { "name": "vaccinated", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Neuroganics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "5 Years to 99 Years" }, "enrollment_count": 100000, "start_date": "2022-03-15", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 1, "location_summary": "Northglenn, Colorado", "locations": [ { "city": "Northglenn", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05095844" }, { "nct_id": "NCT02687763", "title": "Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "RENAL INSUFFICIENCY, CHRONIC", "LIVER FAILURE, ACUTE", "HEART DISEASE" ], "interventions": [ { "name": "ProQuad", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "6 Months to 24 Months" }, "enrollment_count": 5, "start_date": "2015-12", "completion_date": "2016-11-03", "has_results": false, "last_update_posted_date": "2019-02-12", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02687763" }, { "nct_id": "NCT05630846", "title": "A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Measles; Mumps; Rubella; Chickenpox", "Measles" ], "interventions": [ { "name": "Investigational MMRV(H)NS vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational MM(H)RVNS vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational M(L)M(L)R(L)V(L)NS vaccine", "type": "BIOLOGICAL" }, { "name": "Marketed MMRV_Lot 1 and Lot 2 vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 801, "start_date": "2022-12-14", "completion_date": "2024-10-14", "has_results": true, "last_update_posted_date": "2025-06-22", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Jonesboro, Arkansas • Bellflower, California + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05630846" }, { "nct_id": "NCT00384397", "title": "A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "249 Days", "maximum_age": "305 Days", "sex": "ALL", "summary": "249 Days to 305 Days" }, "enrollment_count": 1128, "start_date": "2006-09", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 39, "location_summary": "Montgomery, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 35 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384397" }, { "nct_id": "NCT00505063", "title": "Prospective Trial of Vaccine Responses in Childhood Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Childhood Cancer", "Multiple Diseases" ], "interventions": [ { "name": "Immunization Schedule patients <7 years.", "type": "BIOLOGICAL" }, { "name": "Immunization Schedule patients > or = to 7 years and <11 years of age", "type": "BIOLOGICAL" }, { "name": "Immunization Schedule patients > or = to 11 years of age", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 75, "start_date": "2007-07-10", "completion_date": "2025-06-11", "has_results": true, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00505063" }, { "nct_id": "NCT06693895", "title": "A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chickenpox" ], "interventions": [ { "name": "Investigational varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, and rubella vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" }, { "name": "PCV (pneumococcal conjugate vaccine) 13", "type": "BIOLOGICAL" }, { "name": "PCV 20", "type": "BIOLOGICAL" }, { "name": "Vaxneuvance", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 750, "start_date": "2024-11-26", "completion_date": "2026-11-23", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 22, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Huntington Park, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Park", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "West Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06693895" }, { "nct_id": "NCT00138255", "title": "Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "16 Months", "sex": "ALL", "summary": "Up to 16 Months" }, "enrollment_count": 32, "start_date": "2004-06", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2010-08-27", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00138255" }, { "nct_id": "NCT00258726", "title": "Immune Responses to Two Dose Varivax +/- MMR-II", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "MMR-II", "type": "BIOLOGICAL" }, { "name": "Pro-Quad", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "12 Months to 12 Months" }, "enrollment_count": 105, "start_date": "2005-10", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2010-08-27", "last_synced_at": "2026-10-10T16:49:51.964Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00258726" } ] }